Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 12, 2009
Patent Application Number
09525797
Date Filed
March 15, 2000
Patent Primary Examiner
Patent abstract
The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
